These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38573131)

  • 1. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.
    Smith MC; Klein P; Krauss GL; Rashid S; Seiden LG; Stern JM; Rosenfeld WE
    Neurol Ther; 2022 Dec; 11(4):1705-1720. PubMed ID: 36057761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.
    Rodríguez-Uranga JJ; Sánchez-Caro JM; Hariramani Ramchandani R
    Epilepsia Open; 2024 Aug; 9(4):1345-1356. PubMed ID: 38800945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cenobamate add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Lattanzi S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014941. PubMed ID: 39087564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study.
    Serrano-Castro PJ; Ramírez-García T; Cabezudo-Garcia P; Garcia-Martin G; De La Parra J
    CNS Drugs; 2024 Feb; 38(2):141-151. PubMed ID: 38265735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
    Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
    Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
    Sperling MR; Klein P; Aboumatar S; Gelfand M; Halford JJ; Krauss GL; Rosenfeld WE; Vossler DG; Wechsler R; Borchert L; Kamin M
    Epilepsia; 2020 Jun; 61(6):1099-1108. PubMed ID: 32396252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.
    Steinhoff BJ; Ben-Menachem E; Klein P; Peltola J; Schmitz B; Thomas RH; Villanueva V
    Ther Adv Neurol Disord; 2024; 17():17562864241256733. PubMed ID: 38883228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
    Aboumatar S; Ferrari L; Stern S; Wade CT; Weingarten M; Connor GS; Rosenfeld WE
    Epilepsy Res; 2024 Feb; 200():107306. PubMed ID: 38340681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study.
    Winter Y; Abou Dargham R; Patiño Tobón S; Groppa S; Fuest S
    CNS Drugs; 2024 Sep; 38(9):733-742. PubMed ID: 39096467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion.
    Steinhoff BJ; Rosenfeld WE; Serratosa JM; Brandt C; Klein P; Toledo M; Krauss GL
    Epilepsy Behav; 2021 Oct; 123():108270. PubMed ID: 34509033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
    Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
    Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam.
    Steinhoff BJ; Georgiou D; Intravooth T
    Epilepsia Open; 2024 Aug; 9(4):1502-1514. PubMed ID: 38861254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study.
    Novitskaya Y; Schütz E; Metternich B; Schulze-Bonhage A; Hirsch M
    Epilepsia; 2024 Mar; 65(3):630-640. PubMed ID: 38135903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of efficacy and adverse events during Cenobamate titration period.
    Steinhoff BJ; Ben-Menachem E; Brandt C; García Morales I; Rosenfeld WE; Santamarina E; Serratosa JM
    Acta Neurol Scand; 2022 Sep; 146(3):265-275. PubMed ID: 35711112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A "real-world" retrospective study.
    Peña-Ceballos J; Moloney PB; Munteanu T; Doyle M; Colleran N; Liggan B; Breen A; Murphy S; El-Naggar H; Widdess-Walsh P; Delanty N
    Epilepsia; 2023 May; 64(5):1225-1235. PubMed ID: 36790345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
    Roberti R; De Caro C; Iannone LF; Zaccara G; Lattanzi S; Russo E
    CNS Drugs; 2021 Jun; 35(6):609-618. PubMed ID: 33993416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
    O'Dwyer R; Stern S; Wade CT; Guggilam A; Rosenfeld WE
    Drugs Aging; 2024 Mar; 41(3):251-260. PubMed ID: 38446341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.